EUVIMEDEUVIMED entdecken
Crossref

Development of an isoform-discriminating RT-qPCR assay for transcript-level profiling of human ASAH2 in colorectal cancer cell models

You Shan Ngui, Yi-Wen Huang, Shao-Chi Hung, Shih-Han Huang, Chieh-Ju Wen, Yi-An Chang, Hsing-Chen Wu, Hsiu-Chuan Chan, Mei-Lin Chan, Liang-Yin Ke, Hua-Chen Chan

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-12561-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 18.08.2026. Verfasst von You Shan Ngui und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, 807378, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Real-Time Polymerase Chain Reaction. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Science and Technology Council, Kaohsiung Medical University, I-Shou University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N-Acylsphingosine Amidohydrolase 2 (ASAH2) encodes neutral ceramidase (nCDase), one of several ceramidases involved in sphingolipid metabolism. nCDase hydrolyzes ceramide into sphingosine and contributes to the regulation of the ceramide–sphingosine-1-phosphate signaling axis. Compared with acid and alkaline ceramidases, nCDase remains less well characterized, and the expression and functional relevance of alternatively spliced ASAH2 isoforms are poorly understood. Dysregulated ASAH2 expression has been implicated in colorectal cancer (CRC), suggesting that transcript-level analysis may provide useful information regarding ASAH2 regulation in tumor-related contexts. Human ASAH2 exists as two alternatively spliced isoforms that differ within the catalytic domain, but their accurate quantification is complicated by the highly homologous paralog ASAH2B. We developed an RT-qPCR-based method that combines a universal primer set for total ASAH2 with an isoform 1-specific primer set, enabling differential quantification of ASAH2 isoforms without detectable amplification of the homologous ASAH2B paralog. Absolute quantification was performed using standard curves generated from sequence-verified amplicons. Both assays demonstrated linear amplification over a range of 10²–10⁷ copies, with high correlation coefficients (r² = 0.999 for both assays). Melting curve analysis and agarose gel electrophoresis confirmed single, specific amplification products. Application of this assay to human CRC cell lines revealed that isoform 2, estimated by subtracting the isoform 1 copy number from the total ASAH2 copy number, was the predominant ASAH2 transcript across all tested cell lines. This assay provides a practical approach for transcript-level profiling of ASAH2 isoforms in colorectal cancer cell models and may support future studies of ASAH2 isoform regulation in tumor-related laboratory investigations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsReal-Time Polymerase Chain ReactionHumansProtein IsoformsCell Line, TumorAlternative SplicingIsoenzymesGene Expression Regulation, NeoplasticGene Expression ProfilingAlkaline CeramidaseNeutral Ceramidase

Stichwörter der Autor:innen

Colorectal cancer (CRC)Isoform-specific quantificationN-acylsphingosine amidohydrolase 2 (ASAH2)Neutral ceramidase (nCDase)Reverse transcription quantitative polymerase chain reaction (RT-qPCR)

Substanzen

Protein IsoformsASAH2 protein, humanIsoenzymesAlkaline CeramidaseNeutral Ceramidase

Autor:innen und Institutionen

  • Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, 807378, Kaohsiung, Taiwan.
  • PhD program in Life Science, College of Life Science, Kaohsiung Medical University, Kaohsiung, 807378, Taiwan.
  • Department of Surgery, MacKay Memorial Hospital, Taipei, 104217, Taiwan.
  • Department of Medicine, MacKay Medical College, New Taipei City, 252005, Taiwan.
  • Department of Medical Research, Mackay Memorial Hospital, New Taipei City, 251020, Taiwan.
  • Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, 807378, Kaohsiung, Taiwan. kly@gap.kmu.edu.tw.

Förderung

  • National Science and Technology Council
  • Kaohsiung Medical University
  • I-Shou University

Zitieren

APA

Ngui, Y. S., Huang, Y. W., Hung, S. C., Huang, S. H., Wen, C. J., Chang, Y. A., Wu, H. C., Chan, H. C., Chan, M. L., Ke, L. Y., & Chan, H. C. (2026). Development of an isoform-discriminating RT-qPCR assay for transcript-level profiling of human ASAH2 in colorectal cancer cell models. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12561-9

Vancouver

Ngui YS, Huang YW, Hung SC, Huang SH, Wen CJ, Chang YA, et al. Development of an isoform-discriminating RT-qPCR assay for transcript-level profiling of human ASAH2 in colorectal cancer cell models. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12561-9

BibTeX
@article{Ngui2026,
  author = {Ngui, You Shan and Huang, Yi-Wen and Hung, Shao-Chi and Huang, Shih-Han and Wen, Chieh-Ju and Chang, Yi-An and Wu, Hsing-Chen and Chan, Hsiu-Chuan and Chan, Mei-Lin and Ke, Liang-Yin and Chan, Hua-Chen},
  title = {Development of an isoform-discriminating RT-qPCR assay for transcript-level profiling of human ASAH2 in colorectal cancer cell models},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-12561-9}
}
Kostenlos starten →